Jozef Haring, Georgi Krastev, Ivan Vulev, Andrej Klepanec, Miroslav Mako, Martin Kuchárik, Rastislav Bažík, Tibor Balázs, Ján Haršány, Rastislav Lackovič, Lucia Mokošová, Ivana Zajičková, Ľubica Beňová, Zuzana Števková, Žofia Kovácsová, Petra Došeková, Juraj Cisár, Martina Cabúková, Mária Vomastová
Introduction: rapid and effective revascularization is the mainstay of treatment of ischemic stroke. Until recently, intravenous
thrombolysis used to be the only proven therapeutic modality. Based on the published clinical trials that point
to the benefits of endovascular treatment of acute ischemic stroke in the case of proximal arterial occlusion in the anterior
circulation, this treatment has become a new acute ischemic stroke treatment standard since February 2015.
Objective: Presentation of the outcomes of the endovascular treatment implementation at the Cerebrovascular Centre
of Trnava University Hospital.
Methods: Use the BATTS registry database and the BATTS (Bratislava-Trnava Thrombectomy Study) results to statistically
process the clinical and radiological outcomes of patients treated with endovascular therapy in the period from
May 2013 to June 2016.
Results: A total of 142 patients were treated with endovascular therapy during the reporting period. Within the BATTS
registry 120 patients were analysed with complete 3 months follow up after endovascular treatment. Successful recanalization
(TICI 2b-3) was achieved in 73% of patients, and 31% of patients were in a good clinical condition (mRs 0-2).
Conclusion: analysis of our set points to the benefits of endovascular therapy for the patients with proximal arterial occlusion
within 6 hours, which is documented by clinical outcome (mRs 0-2), similarly as disclosed in the context of major
clinical trials, and an unambiguous prognostically significant parameter of patients´ good functional condition is the
shortest possible time from ischemic stroke formation until occluded artery recanalization.